E. Chetaille

Most-cited papers

1. Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth

   L. Roumenina, Marie Daugan, Rémi Noé, F. Petitprez +29 more

   2019Cancer immunology research221 citations Open access

   Semantic Scholar

   Save

2. Retrospective study of 70 cases of severe frostbite lesions: a proposed new classification scheme

   E. Cauchy, E. Chetaille, V. Marchand, B. Marsigny

   2001Wilderness & environmental medicine (Print)115 citations Open access

   Semantic Scholar

   Save

3. A controlled trial of a prostacyclin and rt-PA in the treatment of severe frostbite.

   E. Cauchy, Benoît Cheguillaume, E. Chetaille

   2011New England Journal of Medicine105 citations Open access

   Semantic Scholar

   Save

4. The role of bone scanning in severe frostbite of the extremities: a retrospective study of 88 cases

   E. Cauchy, E. Chetaille, M. Lefèvre, E. Kerelou +1 more

   2000European Journal of Nuclear Medicine61 citations

   Semantic Scholar

   Save

5. A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial Cancer

   P. Pautier, I. Vergote, F. Joly, B. Melichar +11 more

   2017International Journal of Gynecologic Cancer39 citations Open access

   Semantic Scholar

   Save

6. Efficacy of the Antibody–Drug Conjugate W0101 in Preclinical Models of IGF-1 Receptor Overexpressing Solid Tumors

   B. Akla, M. Broussas, N. Loukili, A. Robert +11 more

   2019Molecular Cancer Therapeutics19 citations

   Semantic Scholar

   Save

7. [Convulsive crisis associated with an overdose of cefepime].

   E. Chetaille, L. Hary, B. de Cagny, V. Gras-Champel +2 more

   1998The´rapie (Paris)14 citations

   Semantic Scholar

   Save

8. ANCHOR CRC: a phase 2, open-label, single arm, multicenter study of encorafenib (ENCO), binimetinib (BINI), plus cetuximab (CETUX) in patients with previously untreated BRAF V600E-mutant metastatic colorectal cancer (mCRC).

   A. Grothey, R. Yaeger, David Páez, J. Tabernero +6 more

   2019Annals of Oncology11 citations Open access

   Semantic Scholar

   Save

9. Population Pharmacokinetic Modelling of Irosustat in Postmenopausal Women with Oestrogen-Receptor Positive Breast Cancer Incorporating Non-Linear Red Blood Cell Uptake

   Z. Parra-Guillén, Josep María Cendrós Carreras, C. Peraire, R. Obach +3 more

   2014Pharmaceutical Research10 citations

   Semantic Scholar

   Save

10. [Antibiotic-associated pseudomembranous colitis: retrospective study of 48 cases diagnosed by colonoscopy].

    Michel Andréjak, B. Lafon, G. Decocq, E. Chetaille +3 more

    1996The´rapie (Paris)9 citations

    Semantic Scholar

    Save

11. [Extrapyramidal disorders induced by veralipride (Agreal). Apropos of 5 cases].

    K. Masmoudi, G. Decocq, E. Chetaille, A. Rosa +2 more

    1995The´rapie (Paris)9 citations

    Semantic Scholar

    Save

12. 7047 POSTER A Phase I Pharmacodynamic Dose Escalation Study of Steroid Sulphatase Inhibitor Irosustat in Patients With Prostate Cancer

    S. Denmeade, D. George, G. Liu, C. Peraire +4 more

    20116 citations

    Semantic Scholar

    Save

13. IMPUTABILITE DE LA MINOCYCLINE DANS DEUX OBSERVATIONS DE PANCREATITE AIGUE

    E. Chetaille, R. Delcenserie, T. Yzet, G. Decocq +2 more

    19986 citations

    Semantic Scholar

    Save

14. Abstract 3372: VISTA interaction with PSGL1, a likely VISTA receptor in tumors, is effectively disrupted by K0401-020 anti-VISTA antibody

    F. Cruzalegui, N. Loukili, O. Delfour, N. Boute +8 more

    2020Immunology5 citations

    Semantic Scholar

    Save

15. Abstract 815: New approach for old target: W0101 antibody drug conjugate effectively inhibits tumor growth in preclinical models of IGF-1R overexpressing solid tumors

    B. Akla, N. Loukili, A. Robert, Charlotte Beau-Larvor +8 more

    2018Experimental and Molecular Therapeutics3 citations

    Semantic Scholar

    Save

16. [Minocycline involvement in two cases of acute pancreatitis].

    E. Chetaille, R. Delcenserie, T. Yzet, G. Decocq +2 more

    1998Gastroentérologie Clinique et Biologique3 citations

    Semantic Scholar

    Save

17. [Is hemodialysis a risk factor for tendinopathies due to fluoroquinolones?].

    G. Decoq, P. Morinière, I. Dufour, E. Chetaille +1 more

    1997The´rapie (Paris)3 citations

    Semantic Scholar

    Save

18. [Convulsions associated with the administration of excessive dose of ceftazidime in patients with renal failure].

    E. Chetaille, K. Masmoudi, L. Dimier-David, L. Hary +2 more

    1994The´rapie (Paris)3 citations

    Semantic Scholar

    Save

19. 315 W0180 novel anti-VISTA antibody: Rationale for target patient population and first-in-human trial design in monotherapy and in combination with anti-PD1 antibody

    I. Melero, C. Gomez-Roca, P. Ferré, E. Chetaille +7 more

    2020Journal for ImmunoTherapy of Cancer2 citations Open access

    Semantic Scholar

    Save

20. Abstract 2400: K01401-020 is a novel anti-VISTA antibody for cancer treatment: Pharmacodynamic impact on non-human primates and human immune system

    N. Loukili, I. Vandenberghe, O. Delfour, F. Fraboul +4 more

    2019Immunology1 citations

    Semantic Scholar

    Save

21. Randomized, double-blind, placebo-controlled proof of concept study of tasquinimod maintenance therapy in patients with metastatic castrate-resistant prostate cancer (mCRPC) who experience response or stabilization during first-line docetaxel chemotherapy.

    K. Fizazi, A. Heidenreich, G. Daugaard, J. Bellmunt +2 more

    20131 citations

    Semantic Scholar

    Save

22. 2731 Impact of frailty on outcome of elderly patients treated with hormone therapy for advanced/recurrent endometrial cancer (EC)

    F. Joly, Patricia Pautier, I. Vergote, B. Melichar +11 more

    20150 citations

    Semantic Scholar

    Save